The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy. [electronic resource]
Producer: 19711116Description: 648-52 p. digitalISSN:- 0007-1323
- Acid Phosphatase -- blood
- Aged
- Clinical Trials as Topic
- Drug Hypersensitivity
- Humans
- Injections, Intramuscular
- Male
- Middle Aged
- Organ Size
- Placebos
- Pregnanes -- adverse effects
- Progestins -- adverse effects
- Prostate -- diagnostic imaging
- Prostatic Hyperplasia -- drug therapy
- Pyuria -- complications
- Thyroid Gland -- drug effects
- Urinary Catheterization
- Urography
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.